Recombinant Human Bone morphogenetic protein 2 (BMP2) (Active) - CD BioSciences

service-banner

Recombinant Human Bone morphogenetic protein 2 (BMP2) (Active)

Recombinant Human Bone morphogenetic protein 2 (BMP2) (Active)

SPP-00669

Size Price
1 mg Online Inquiry
500 μg Online Inquiry
50 μg Online Inquiry
10 μg Online Inquiry
Target Information
Species Homo sapiens
Target Name BMP-2
UniProt No. P12643
Subcellular Location Secreted
Tissue Specificity Particularly abundant in lung, spleen and colon and in low but significant levels in heart, brain, placenta, liver, skeletal muscle, kidney, pancreas, prostate, ovary and small intestine.
Gene Abbr. BMP2
Full Name bone morphogenetic protein 2
Alias BDA2, BMP2A, SSFSC
Introduction Bone morphogenic protein 2 is required for effective healing of fractures in bone. It is necessary for the expression of transcription factors that regulate osteogenesis and differentiation of progenitor cells into mature osteoblasts. Embryologically, BMP2 is important in mesenchymal maturation to fetal valves. The same mechanism of maturation is also utilized by tumor molecular machinery once mesenchymal stem cells are recruited to tumor microenvironments, leading to many recent attempts to generate BMP inhibitors in the treatment of ovarian and colon cancer. The activity of BMP2 is antagonized by the activity of Bambi and Crim1. BMP2 is an interesting target for distinguishing the mechanism by which normal and necessary maturation processes are mutated in tumorigenesis.
Product Details
Product Type Recombinant Protein
Product Form Lyophilized powder
Buffer before Lyophilization Lyophilized from a 0.2 μm filtered 10 mM NH4-HAc, pH 4.0.
Storage & Handling
Storage Temp. Store at -20 °C upon receipt unless otherwise instructed.
Handling Aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.

For research use only. Not intended for any clinical use. No products from CD BioSciences may be resold, modified for resale or used to manufacture commercial products without prior written approval from CD BioSciences.